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Cardiovascular disease (CVD) is one of
the leading causes of death and disability
worldwide, accounting for 16.7 million
(29.2%) of total global deaths, 80% of them
taking place in low- or middle-income
countries [1]. While death is inevitable,
premature death and loss of productive
years of life from CVD is, for the most part,
preventable. Much can be achieved by
population-wide interventions that seek to
lower cigarette and salt consumption,
obesity prevalence, and blood cholesterol
levels in the entire population [2]. At a
personal healthlevel, there is an abundance
of evidence that reducing modifiable CVD
risk factors (smoking, lipid fractions, blood
pressure, diabetes) through drug, dietary,
and other interventions can prevent or
delay CVD events. Almost all adults could
achieve a 50%–80% relative reduction in
CVD risk if they took a combination of a
lipid-lowering drug, a blood pressure low-
ering drug, and aspirin [3]. The higher the
pre-treatment CVD risk, the greater the
absolute benefit and therefore the greater
the cost-effectiveness of treatment [4].
Therefore, many national guidelines now
advocate identifying those at high risk of a
future CVD event in the short-term and
tailoring the intensity of management for
individuals according to their baseline
CVD risk.
Is CVD Risk Reduction
Happening in Practice?
Large gaps have been demonstrated
between what is known to be effective and
what is actually done in health care [5,6].
Studies have shown that a formal CVD
risk assessment to systematically identify
high-risk patients is rarely conducted [7,8],
and audits of care indicate substantial
under-use of effective CVD interventions
by clinicians [9–12].
The reasons why clinicians do not
follow patient management guidelines
have been explored in some depth [13–
15] and reflect a complex interplay of
organisational, health system, provider,
and patient factors. Barriers include lack
of time, heavy workload and other com-
peting demands, a lack of teamwork and
organisation in the practice, paperwork,
bureaucracy, and a lack of support to
conduct preventive care [13–15]. Guide-
lines have been criticised for being too
complex and focused on single diseases,
whereas patients present with multiple
problems. Even if clinicians have the
ability, time, and resources to act on the
evidence, for management to be effective
the patient needs to understand and agree
with the approach, be motivated to make
changes, and be willing and able to adhere
to a management plan.
Can Technological Innovation
Help to Close the CVD
Evidence-Practice Gap?
There is growing interest in the poten-
tial of information technology (IT) to
reduce human error and variation in
patient care. A recent systematic review
has investigated the impact of a wide
range of health IT [16]. Three major
benefits were found for quality of care
(particularly in association with preventive
care):
N increased adherence to guideline-
based care;
N enhanced surveillance and monitoring;
and
N decreased medication errors.
Table 1 shows where health IT could be
used to support the process of CVD risk
assessment and management in primary
care practices. The focus is on tailoring
interventions to specific patients based on
recorded data and thus providing person-
alised prevention.
Most of these technologies are predicat-
ed on
N the presence of an electronic medical
record (EMR, defined as computer-
based clinical data of an individual
that are location-specific and kept by a
single practice or office, health centre,
or ambulatory clinic [17]); and
N the ability to register patients, query
the database to identify patients of
interest, and contact them.
Electronic queries to identify those
eligible for CVD risk assessment and
utilisation of simple rules-based automated
reminder and recall systems have been
increasingly used internationally since the
late 1970s. Electronic calculators for
estimates of CVD risk have been available
since the early 1990s. However, only
recently have more patient- and clini-
cian-friendly CVD risk communication
tools been developed (see Box 1 for an
example).
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(CDSSs) can rapidly and automatically
convert the recommendations from evi-
dence-based syntheses into guidance for
clinicians, tailored for an individual pa-
tient’s profile. Systematic reviews have
found moderate evidence of CDSS effec-
tiveness with respect to provider processes
and performance, but the effects on
patient outcomes are understudied and,
where research has been conducted,
inconsistent [18–20].
E-prescribing and e-referrals are becom-
ing widespread in countries with a high
degree of practice computerisation and
Internet connectivity. The challenge is to
add value to this system via more extensive
two-way sharing of information. This could
include notification of filled prescrip-
tions and alerts in the practice system for
un-filled prescriptions; notification of
changes to care plans and medications by
other providers; and missed appointments
at other health services.
CDSSs can also form the basis of shared
goal setting and the development of care
plans for risk reduction. Instant electronic
access and registration into self-manage-
ment programmes removes barriers, such
as having to attend another session, uses
the ‘‘teachable moment’’ (i.e., being in-
formed one is at high risk of an acute
cardiac event) to enhance motivation, and
can involve the primary care provider to
motivate and tailor appropriately to the
individual’s risk profile. Internet-based
programmes to support self-management
and healthy behaviour change are prolif-
erating. While there is limited evidence for
effectiveness of IT-based self-management
programmes, smoking cessation is one
area that has been rigorously trialled. A
recent meta-analysis of 22 randomised
controlled trials found ‘‘… sufficient clin-
ical evidence to support the use of Web-
and computer-based smoking cessation
programs for adult smokers’’ (RR 1.44,
90% confidence interval 1.27–1.64) [21].
Social networking Web sites are also being
used formally and informally for such
support. Patientslikeme.com is just one
example of harnessing social networking
to provide peer support for patients with
the same conditions [22]. However, the
social networking phenomenon does not
easily lend itself to rigorous research of
effectiveness.
Electronic patient portals or patient
access to electronic health records can
further empower patients to manage their
disease and become active participants in
their own health outcomes. However,
there is limited research published on the
effectiveness of these tools with respect to
health outcomes, particularly for CVD.
Telehealth interventions include any
telecommunications between a provider
and patient between clinic visits, such as
via phone, Internet, videoconference com-
munication, and text messaging. A sys-
tematic review of telehealth interventions
for the secondary prevention of coronary
disease found significant differences in
smoking, lipid levels, and systolic blood
pressure in patients taking part in such
interventions [23]. Mobile phones are
likely to play an important role here in
the future, allowing behaviour change
Summary Points
N Cardiovascular disease (CVD) risk management through drug, dietary, and other
interventions can significantly prevent or delay CVD events.
N Despite evidence for effectiveness, large gaps have been demonstrated
between what is known and what is actually done in health care.
N Information technology (IT) has the potential to support clinicians to close
these gaps throughout processes of care delivery.
N IT can be used to support identification of at-risk individuals, CVD risk
assessment and management, care planning, patient self-management, and
evaluation of improvements in care and health outcomes.
N To achieve the potential of IT-based programmes requires a supportive social
and political environment, substantial organisational changes, and active
patient and clinician engagement.
Table 1. Health IT Support for CVD Risk Assessment and Management Processes in Primary Care.
Process of Care Examples of IT Support
Identification of eligible population Electronic query of age/sex registers
Recalls and reminders Automated patient reminder and recall letter plus laboratory forms
Automated clinical reminder at time of consultation
CVD risk assessment Electronic risk calculator
CVD risk communication Electronic pictorial clinical and patient decision aids
CVD risk management Computerised decision support tools integrated with the electronic patient medical record
CVD risk factor reduction Internet and mobile phone-based behaviour change support programmes
Referral to speciality services; other clinical ordering E-prescriptions and e-referrals with electronic communication back to primary care
Telemedicine remote specialist consultations
Long-term chronic disease management/self-care E-guidelines-based care plans and goal setting
E-mail and mobile communications between visits
Remote monitoring
Patient access to their electronic health records
Internet/mobile patient social support networks
Monitoring of processes, service performance, and quality improvement Automated audit and feedback tools to clinicians and patients
Monitoring of outcomes Electronic linkage of clinical profiles to health outcomes (e.g., mortality and hospitalisations)
doi:10.1371/journal.pmed.1000313.t001
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people wherever they are in formats from
simple SMS/text messages to multimedia
video messages. Such programmes can be
tailored and personalised, and yet are
eminently scalable to large diverse popu-
lations (see Box 2 for an example). Two
recent systematic reviews of health care
delivered via mobile phone found 26
studies in smoking cessation, diabetes
care, physical activity, stress manage-
ment, hypertension, and other conditions
[24,25]. These reviews reported signifi-
cant behaviour change, with clinical and
process improvements in the majority of
studies.
Telemedicine has also taken the form
of live remote specialist consultation (for
patients in geographically isolated areas),
or the transmission of diagnostic images/
video/data for review by specialists. This
also includes remote monitoring at home
by devices that transmit data (e.g., ECG,
blood pressure, weight, blood glucose) to
a health care provider for interpreta-
tion and alterations to care. Home-based
telemonitoring using Internet and mobile
phone technology has been demonstrated
to reduce hospital admissions for those
with congestive heart failure and, if
admitted, to reduce the length of stay
[26,27].
Finally, IT support is vital for monitor-
ing processes and outcomes for clinical
audit and research with pay-for-perfor-
mance programmes such as the United
Kingdom quality and outcomes frame-
work based on the necessity of an ‘‘IT
spine’’. Health IT records are increasingly
being used for CVD research, for exam-
ple, to generate large risk prediction
cohorts [28,29].
What Is Needed to Implement a
Systematic Technology-Based
Approach for CVD?
The benefits of implementing a system-
atic health IT approach could include
improvements in the quality of care,
reduced duplication, improving access to
services in areas of growing demand and
limited resources, and improved monitor-
ing and evaluation. However, while some
health IT systems implementations suc-
ceed, the majority are likely to fail [30].
The greater the personal and organisa-
tional change required by a system, the
greater the risk of failure. Adverse effects
of health IT implementation can include
increased time for direct and indirect
patient care [31], the loss of privacy and
confidentiality, and possible changes to the
doctor–patient relationship [32]. The time
commitment involved with learning and
implementing new systems may be sub-
stantial. The set-up costs of computerisa-
tion and implementation of health IT can
be large and require ongoing investment.
Furthermore, IT is a rapidly evolving
science. By the time a large-scale project
is completed, technology has often moved
on [33].
Key elements that facilitate the devel-
opment of a systematic technology-based
approach are the availability of high
quality national or international CVD
guidelines, and local health IT specialists
with the ability to develop reliable systems
and the willingness and resources to
maintain, sustain, and continue to inno-
vate in response to consumer, clinician,
and local health service needs. At a
national level, policies that support pre-
vention of CVD and long-term condition
management need to be aligned with
national IT policies that support the
development of unified informatics stan-
dards for collecting health data, coding,
messaging, and network infrastructure.
While privacy and confidentiality con-
cerns remain, there is a need for mature
privacy statutes and ensuring consumers
are aware of the potential uses of their
health data.
Without clinical and health service buy-
in, no IT solution will be successful. The
solutions need to be effective, user-friend-
ly, and integrated with all other systems,
and ultimately must be efficient in terms of
person-time. Berg describes this as a ‘‘…
process of mutual transformation …’’
involving organisational change and al-
lowing for change in the IT strategy
arising out of the process of implementa-
tion [34].
In summary, CVD management re-
quires partnerships between providers
and patients, between staff within an
institution, between service providers in
the primary care setting, and between
primary, secondary, and tertiary care
services. For IT to achieve the potential
to close the gap between evidence and
practice and translate into positive patient
outcomes there needs to be teamwork and
a change in the way clinicians and
services work together. This is particularly
important for long-term health conditions
such as CVD, where there is often
unbounded need in the face of limited
resources.
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